Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual vs Oral Estradiol PK in Transgender Women
NCT04036500Phase 1Completed
- Sponsor
- Medical College of Wisconsin
- Start
- Sep 2019
- Primary completion
- Jul 2020
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of estradiol in gender dysphoria (GD), sponsored by Medical College of Wisconsin. Primary endpoints: Maximum Serum Concentration of Estradiol at 8 hours, Area Under the Serum Concentration Versus Time Curve at 8 hours and 1 more. Started Sep 2019; status: completed.
02
Drugs
estradiol
03
Conditions
gender dysphoria (GD)
Beyond the preview
Go deeper on NCT04036500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04036500.